Premium
Mumbai-based JB Chemicals & Pharmaceuticals Ltd, which is majority-owned by private equity firm KKR, is looking to acquire the Indian eyecare portfolio of drug major Novartis, a media report said. Novartis is planning to sell the portfolio in a deal estimated to be around Rs 1,000 crore, The Times of India ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.